Michael Kapinsky

Krefeld, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Expanding the supply of human leukocytes for research by harvesting cell concentrates from Trima Accel tubing sets.

Expanding the supply of human leukocytes for research by harvesting cell concentrates from Trima Accel tubing sets.

Journal: Scientific reports
Published: March 16, 2026

Superior precision of clinical predictions after CD3-relativisation to align flow cytometry data.

Superior precision of clinical predictions after CD3-relativisation to align flow cytometry data.

Journal: EBioMedicine
Published: October 17, 2025

An Update on Flow Cytometry Analysis of Hematological Malignancies: Focus on Standardization.

An Update on Flow Cytometry Analysis of Hematological Malignancies: Focus on Standardization.

Journal: Cancers
Published: April 29, 2025

Restricting datasets to classifiable samples augments discovery of immune disease biomarkers.

Restricting datasets to classifiable samples augments discovery of immune disease biomarkers.

Journal: Nature communications
Published: May 04, 2023

External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition.

External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition.

Journal: Frontiers in immunology
Published: August 03, 2022

Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications.

Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications.

Journal: Frontiers in immunology
Published: August 27, 2021

Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications.

Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications.

Journal: Frontiers in immunology
Published: January 25, 2021

Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

Journal: Lancet (London, England)
Published: November 15, 2019

Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.

Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.

Journal: Transplantation research
Published: June 12, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026